Sequenom (SQNM) Posts Q1 Profit of $0.12/Share

Go back to Sequenom (SQNM) Posts Q1 Profit of $0.12/Share

Oppenheimer Sees Increased Clarity at Sequenom (SQNM)

May 8, 2015 11:27 AM EDT

Oppenheimer analyst Ling Wang reiterated an Outperform on Sequenom (NASDAQ: SQNM) following Q1 results, saying gaining clarity on royalty conversion.

Wang commented, "Slightly soft diagnostic revenues were offset by new licensing fee revenue from the patent pool. The final payment... More

Wedbush Downgrades Sequenom (SQNM) to Neutral

May 7, 2015 8:41 AM EDT

Wedbush downgraded Sequenom (NASDAQ: SQNM) from Outperform to Neutral with a price target of $4.50 (unchanged).

For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.

Shares of Sequenom closed at $4.47 yesterday.

... More